Q.E.P. Co., Inc. (QEPC)
OTCMKTS · Delayed Price · Currency is USD
38.80
-1.13 (-2.82%)
Aug 1, 2025, 3:54 PM EDT
CTI BioPharma Income Statement
Financials in millions USD. Fiscal year is March - February.
Millions USD. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | 2017 - 2021 |
| 241.84 | 243.83 | 251.99 | 269.45 | 445.53 | 387.6 | Upgrade | |
Revenue Growth (YoY) | -3.08% | -3.24% | -6.48% | -39.52% | 14.95% | -1.60% | Upgrade |
Cost of Revenue | 155.09 | 157.26 | 169.99 | 196.25 | 324.79 | 278.9 | Upgrade |
Gross Profit | 86.74 | 86.57 | 82 | 73.2 | 120.75 | 108.69 | Upgrade |
Selling, General & Admin | 66.03 | 66.33 | 67.9 | 64.06 | 107.31 | 98.34 | Upgrade |
Other Operating Expenses | 0.3 | 0.42 | 0.8 | -0.14 | -0.66 | -1.59 | Upgrade |
Operating Expenses | 66.33 | 66.76 | 68.69 | 63.93 | 106.65 | 96.74 | Upgrade |
Operating Income | 20.41 | 19.81 | 13.3 | 9.27 | 14.1 | 11.95 | Upgrade |
Interest Expense | - | - | -1.39 | -2.09 | -1.26 | -1.6 | Upgrade |
Interest & Investment Income | 0.87 | 0.88 | - | - | - | - | Upgrade |
EBT Excluding Unusual Items | 21.28 | 20.69 | 11.92 | 7.19 | 12.84 | 10.35 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | -0.24 | -0.84 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.02 | Upgrade |
Pretax Income | 21.28 | 20.69 | 11.92 | 7.19 | 12.6 | 9.48 | Upgrade |
Income Tax Expense | 5.03 | 4.98 | 2.79 | 2.7 | 2.95 | 2.58 | Upgrade |
Earnings From Continuing Operations | 16.25 | 15.71 | 9.13 | 4.49 | 9.65 | 6.9 | Upgrade |
Earnings From Discontinued Operations | -0.02 | 0.54 | -13.84 | -4.55 | - | - | Upgrade |
Net Income | 16.23 | 16.25 | -4.71 | -0.06 | 9.65 | 6.9 | Upgrade |
Net Income to Common | 16.23 | 16.25 | -4.71 | -0.06 | 9.65 | 6.9 | Upgrade |
Net Income Growth | - | - | - | - | 39.87% | - | Upgrade |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade |
Shares Change (YoY) | -2.02% | -1.79% | 0.21% | -0.09% | 0.15% | 0.03% | Upgrade |
EPS (Basic) | 4.96 | 4.95 | -1.41 | -0.02 | 2.89 | 2.07 | Upgrade |
EPS (Diluted) | 4.96 | 4.94 | -1.40 | -0.02 | 2.88 | 2.06 | Upgrade |
EPS Growth | - | - | - | - | 39.81% | - | Upgrade |
Free Cash Flow | 4.54 | 8.19 | 27.61 | -2.92 | -12.13 | 24.04 | Upgrade |
Free Cash Flow Per Share | 1.39 | 2.49 | 8.24 | -0.87 | -3.63 | 7.19 | Upgrade |
Dividend Per Share | 0.400 | 0.200 | - | - | - | - | Upgrade |
Gross Margin | 35.87% | 35.50% | 32.54% | 27.17% | 27.10% | 28.04% | Upgrade |
Operating Margin | 8.44% | 8.13% | 5.28% | 3.44% | 3.16% | 3.08% | Upgrade |
Profit Margin | 6.71% | 6.67% | -1.87% | -0.02% | 2.17% | 1.78% | Upgrade |
Free Cash Flow Margin | 1.88% | 3.36% | 10.96% | -1.08% | -2.72% | 6.20% | Upgrade |
EBITDA | 21.83 | 21.2 | 15.96 | 13.07 | 18.27 | 16.54 | Upgrade |
EBITDA Margin | 9.03% | 8.69% | 6.33% | 4.85% | 4.10% | 4.27% | Upgrade |
D&A For EBITDA | 1.42 | 1.39 | 2.66 | 3.8 | 4.18 | 4.59 | Upgrade |
EBIT | 20.41 | 19.81 | 13.3 | 9.27 | 14.1 | 11.95 | Upgrade |
EBIT Margin | 8.44% | 8.13% | 5.28% | 3.44% | 3.16% | 3.08% | Upgrade |
Effective Tax Rate | 23.64% | 24.07% | 23.39% | 37.59% | 23.41% | 27.25% | Upgrade |
Advertising Expenses | - | 0.9 | 0.7 | 3 | 3.4 | 2.9 | Upgrade |
Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.